Amisulpride by Sumitomo Pharma America for Bipolar Disorder (Manic Depression): Likelihood of Approval
Amisulpride is under clinical development by Sumitomo Pharma America and currently in Phase III for Bipolar Disorder (Manic Depression).
Stay updated with breaking news from Manic Depression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amisulpride is under clinical development by Sumitomo Pharma America and currently in Phase III for Bipolar Disorder (Manic Depression).
In addition, a majority of large employers report in a national survey that they are seeing increased mental health issues among workers due to COVID-19.
Journalist David Harper shared details of his diagnosis and the ways it has affected his life in a candid video, which he posted on social media this morning.
Targeting brain networks and circuits, rather than specific brain regions, may be more effective way to develop new treatments for psychiatric disorders, new research hints.
BioXcel Therapeutics said on Monday it will cut more than half of its workforce, as the drugmaker shifts its focus towards developing its agitation treatment for use in at-home settings.